share_log

This Insider Has Just Sold Shares In Clarity Medical Group Holding

This Insider Has Just Sold Shares In Clarity Medical Group Holding

這位內部人士剛剛出售了Clarity Medical Group Holding
Simply Wall St ·  01/29 14:09

We'd be surprised if Clarity Medical Group Holding Limited (HKG:1406) shareholders haven't noticed that the Executive Director, Wai Ip Tse, recently sold HK$2.0m worth of stock at HK$0.61 per share. On the bright side, that sale was only 3.1% of their holding, so we doubt it's very meaningful, on its own.

如果清晰醫療集團控股有限公司(HKG: 1406)的股東沒有注意到執行董事謝偉業最近以每股0.61港元的價格出售了價值200萬港元的股票,我們會感到驚訝。好的一面是,那次出售僅佔他們持股量的3.1%,因此我們懷疑這本身是否有意義。

See our latest analysis for Clarity Medical Group Holding

查看我們對Clarity Medical Group Hold

Clarity Medical Group Holding Insider Transactions Over The Last Year

Clarity Medical Group在過去一年中持有內幕交易

In the last twelve months, the biggest single purchase by an insider was when insider Chi Heng Cheng bought HK$13m worth of shares at a price of HK$1.04 per share. So it's clear an insider wanted to buy, even at a higher price than the current share price (being HK$0.56). Their view may have changed since then, but at least it shows they felt optimistic at the time. In our view, the price an insider pays for shares is very important. It is generally more encouraging if they paid above the current price, as it suggests they saw value, even at higher levels.

在過去的十二個月中,內部人士最大的一次收購是內部人士Chi Heng Cheng以每股1.04港元的價格購買了價值1300萬港元的股票。因此,很明顯,即使價格高於當前股價(0.56港元),內部人士也想買入。從那以後,他們的觀點可能發生了變化,但至少這表明他們當時感到樂觀。我們認爲,內部人士爲股票支付的價格非常重要。如果他們支付的費用高於當前價格,通常會更令人鼓舞,因爲這表明即使在更高的水平上,他們也看到了價值。

In the last twelve months insiders purchased 12.95m shares for HK$14m. On the other hand they divested 6.40m shares, for HK$4.0m. Overall, Clarity Medical Group Holding insiders were net buyers during the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

在過去的十二個月中,內部人士以1400萬港元購買了1295萬股股票。另一方面,他們以400萬港元的價格剝離了640萬股股票。總體而言,去年,Clarity Medical Group Holding的內部人士是淨買家。您可以看到下圖所示的去年的內幕交易(公司和個人)。通過點擊下面的圖表,你可以看到每筆內幕交易的確切細節!

insider-trading-volume
SEHK:1406 Insider Trading Volume January 29th 2024
SEHK: 1406 內幕交易量 2024 年 1 月 29 日

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

還有很多其他公司有內部人士購買股票。你可能不想錯過這份業內人士正在收購的成長型公司的免費名單。

Insider Ownership

內部所有權

Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Clarity Medical Group Holding insiders own about HK$70m worth of shares. That equates to 24% of the company. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

許多投資者喜歡查看公司內部人士擁有多少股份。通常,內部人士的所有權越高,內部人士長期建立公司的可能性就越大。清晰醫療集團控股內部人士擁有價值約7000萬港元的股票。這相當於公司24%的股份。儘管這是一個強勁但並不突出的內部所有權水平,但這足以表明管理層與小型股東之間有一定的一致性。

So What Do The Clarity Medical Group Holding Insider Transactions Indicate?

那麼,持有內幕交易的Clarity Medical Group表明了什麼?

An insider sold Clarity Medical Group Holding shares recently, but they didn't buy any. On the other hand, the insider transactions over the last year are encouraging. We like that insiders own a fair amount of the company. So the recent selling doesn't worry us too much. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Our analysis shows 4 warning signs for Clarity Medical Group Holding (1 doesn't sit too well with us!) and we strongly recommend you look at these before investing.

一位內部人士最近出售了Clarity Medical Group Holding的股票,但他們沒有購買任何股票。另一方面,去年的內幕交易令人鼓舞。我們喜歡內部人士擁有該公司的相當一部分股份。因此,最近的拋售並不讓我們太擔心。因此,這些內幕交易可以幫助我們建立有關股票的論點,但也值得了解這家公司面臨的風險。我們的分析顯示 Clarity Medical Group Holding 有 4 個警告信號(1 個對我們來說不太合適!)我們強烈建議您在投資之前先看看這些。

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

如果你想看看另一家公司——一家財務狀況可能優越的公司——那麼千萬不要錯過這份免費的股本回報率高、債務低的有趣公司的名單。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論